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Background: Accurate and early diagnosis of Visceral Leishmaniasis (VL) is a prerequisite for proper treatment and
restricting disease propagation in enldemic foci. An rK39 antigen-based immunochromatographic test is now
recommended for its diagnostic accuracy and operational feasibility at point of care. In endemic regions of Bangladesh,
rK39 or rKE16 antigen-based Rapid Diagnostic Tests (RDTs) are routinely performed on whole blood for diagnosis of VL.
However, manufacturer’s instructions require use of serum. Therefore, we wanted to assess whether the diagnostic
accuracy of these RDTs is as good on whole blood as on serum.
Methods: We evaluated and compared the sensitivity and specificity of five different commercially available RDTs on
whole blood and on serum. We enrolled 30 VL patients, 35 endemic healthy controls and 30 Tuberculosis (TB) patients
in our study from Mymensingh, a hyper-endemic region in Bangladesh.
Results: The sensitivity of all RDTs ranged between 96.67 % (95 % CI: 82.72-99.44 %) and 100 % (95 % CI: 96.34-100 %).
The specificity ranged between 93.85 % (95 % CI: 84.97-98.26 %) and 98.46 % (95 % CI: 91.69-99.74 %), except for the Onsite
leishmania Ab (Rev B) kit which showed markedly lower specificity (31.25-58.46 %). There was no significant difference in
sensitivity and specificity between blood and serum. The Cohen kappa index (k >0.97) indicated excellent agreement.
Conclusions: We conclude from the study that the use of blood for RDT in lieu of serum is appropriate for diagnosis of
VL in peripheral endemic regions provided the manufacturer recommendations are followed and the RDT is of
good quality.
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Visceral leishmaniasis or kala-azar is a systemic infec-
tion by an obligate intra-cellular parasite, and clinic-
ally manifests as chronic fever, fatigue, weakness, loss
of appetite and weight loss. Hepatosplenomegaly,
anemia, thrombocytopenia and leucopenia are the
most common signs. If left untreated, the disease is* Correspondence: din63d@icddrb.org
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creativecommons.org/publicdomain/zero/1.0/fatal [1]. The disease is vector-borne, and is poverty–
related. In the Indian subcontinent it is caused by
Leishmania donovani. In Bangladesh, people from 45
out of 64 districts face a potential risk of this fatal
disease [2]. Although effective therapies to treat VL
are available now, they are potentially toxic and are
costly [3]. So, accurate diagnosis before treatment is
imperative. In addition to that, visceral leishmaniasis
is anthroponotic in the Indian subcontinent and no
potential vaccine has been developed against VL till
date. So, apart from vector control, early caseticle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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ease propagation [3, 4].
Demonstration of the amastigote parasite from spleen as-
pirates is considered as a gold standard for kala-azar diag-
nosis for its high sensitivity and specificity. However, spleen
aspiration is an invasive method and requires a well-
equipped clinical setting to perform [1]. Aspirates from
bone marrow and lymph glands are associated with less risk
but their sensitivities are not up to the mark [5]. Besides
that, several serological and molecular techniques are avail-
able for diagnosis of VL [6]. Molecular methods require ref-
erence laboratory settings and are not appropriate for first-
line health services. Several serological techniques including
IFAT, ELISA and DAT have been developed, of which the
DAT is most commonly used in field settings for its ease of
execution. However, DAT requires multiple pipetting, is
time consuming to perform, and its reading requires proper
training [6, 7]. Immunochromatographic tests (ICT) are
rapid, reliable, simple and feasible to use at point of care,
and have been recommended for use in first-line health
centres in combination with a clinical case definition [8].
The currently available ICTs are based on rK39 and rKE16
antigen and most of them have to be used on serum sam-
ples [9]. The latter is again a constraint for use in a first-line
health facility with a very basic laboratory.
According to the Bangladeshi national guideline, an rK39
Rapid Diagnostic Test (RDT) is recommended for VL diag-
nosis [10]. Notwithstanding manufacturer’s instructions,
this RDT is routinely performed on whole blood in periph-
eral endemic regions of Bangladesh [3]. In addition to that,
rK39 dipstick tests have been performed throughout the
kala-azar elimination program to do active surveillance
and to detect cases early [11, 12]. Few reports have been
published on the performance of available commercial
RDTs on whole blood compared to serum [3, 5]. It was
therefore imperative to evaluate the diagnostic accuracy of
the available commercial RDTs. So, the aim of our study
was to study the agreement between results obtained in
blood and in serum samples of five different types of RDTs;
three based on rK39 and two on rKE16 antigen.
Methods
Study site
This study was conducted in two sites; the International
Centre for Diarrheal Disease Research, Bangladesh (icddr,b)
and the field site of parasitology laboratory, icddr,b at
Muktagacha, Mymensigh. All participants of this study are
permanent residents of Mymensingh, a hyper-endemic re-
gion in Bangladesh.
Study population
The included participants in this study were divided into
three groups. The first group consisted of 30 active VL pa-
tients without past history of VL. For VL cases ourinclusion criteria was either (a) parasitological confirm-
ation or, (b) diagnosis of VL by National guideline along
with complete clinical cure assessment after 6 months
following treatment [13]. The second group consisted
of 35 healthy controls who had no history of VL infec-
tion, were more than 18 years old and were negative in
the DAT test (titre <1:1600). The third group consisted of
30 TB patients with a positive sputum smear. Patients
below 2 years old were excluded from the study.
Sample collection, transportation and storage
4 ml of blood was drawn from every confirmed VL patient,
endemic healthy control and TB patient. Collected sample
was divided into two parts and then one was transferred in
an EDTA tube and other in an EDTA free tube for separ-
ation of serum. After 20–30 min, clotted blood was centri-
fuged at 2500 rpm for ten min. at room temperature to
separate serum. After that, RDT was performed using fresh
blood and serum . The remaining blood and serum were
stored at −20 °C and transported frozen to the parasitology
laboratory at icddr,b for repeating the tests .
Test kits
Five test kits were selected to perform RDT which fulfilled
the operational criteria developed by the VL Laboratory
Network. Among five test kits, four were received from
two manufacturers, CTK Biotech (Onsite leishmania Ab;
Rev A & Rev B rapid test) and Span Diagnostics products
(Signal-KA and Crystal-KA) and another from Inbios
international Inc. (Kala-azar Detect). After arrival, test kits
were unpacked and stored according to the manufac-
turers’ instructions. Date of arrival, condition of test kits
and product lot numbers were carefully recorded. RDT
characteristics are listed in Table 1.
Test procedure
Prior to performing the test, RDTs were brought to room
temperature and labeled with a random sample code. Each
sample was tested with each of the 5 products according to
manufacturer’s instructions on serum and on blood. At first,
a specific volume of sample was dispensed onto the RDT
by micropipette and then chasing buffer was applied drop-
wise onto the RDT. The test result was interpreted and then
recorded on a standardized form by two technicians at the
minimum reading time and not more than 30 min. The
second technician was blinded to the first technician’s read-
ing. The presence of both a test and a control line was re-
corded as positive and the presence of only a control band
was recorded as negative. The test result was recorded as
invalid if the control band was found to be absent.
Data analysis
A database was generated in EPI-INFO for data storage
and retrieving for further analysis. A double data entry
Table 1 Characteristics of Rapid Diagnostic Tests (RDTs)














Signal®KA Cassette 2–8 °C Yes rkE16 20 μl of serum/blood
in 80 μl of saline.
50 μl of diluted
sample










Ab (Rev A) rapid test





Ab (Rev B) rapid test




Kala azar Detect™ Dipstick 4–30 °C Yes rk39 Blood 20 μl 3 10 10
Serum 20 μl
Table 2 Characteristics of the study subjects
Characteristics VL patients Healthy control Controls
with TB
n = 30 n = 35 n = 30
Age (Years) 18.93 ± 13.08 29.09 ± 8.18 38 ± 18.48
Mean ± SD 16 (53.3) 0 (0) 3 (11.11)
Children (<18 years), n, (%) 14 (46.7) 35 (100) 27 (88.89)
Adult (>18 years), n, (%)
Sex 17 (56.7) 31 (88.6) 17 (56.7)
Male, n (%) 13 (43.3) 4 (11.4) 13 (43.3)
Female, n (%)
Spleen size (cm)a 5.25 ± 3.98 - -
Mean ± SD
Duration of fever (Weeks) 8.53 ± 7.92 - -
Mean ± SD
aSpleen size was measured through abdominal palpation and the length was
measured from the coastal margin along with its axis
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performed by SPSS software. The secured preservation of
all source documents and electronic records was con-
firmed until the accomplishment of the study, data ana-
lysis and data dissemination. We calculated sensitivity and
specificity with 95 % CI using exact binomial methods for
proportions. We used Cohen kappa index for agreement
testing between test results. The values of Cohen κ coeffi-
cients were interpreted according to Landis and Koch;
1.00-0.81: excellent, 0.80-0.61: good, 0.60-0.41: moderate,
0.40-0.21: weak and 0.20-0.00: negligible agreement [9].
Ethical approval
This study was approved by the icddr,b ethical review
committee. Informed written consent was taken from each




The average age was 38 in disease control group, 29 in
healthy control group and in VL patient group it was 18.
The number of male and female participants was compar-
able among VL patients, while in disease control group
the male–female ratio was 1:9 and in healthy control
group it was 8:1. Average spleen size and duration of fever
in VL patient group were 5.25 cm and 8 weeks respect-
ively (Table 2).
Diagnostic performance
All RDTs showed excellent sensitivity and specificity
(healthy and disease control) for fresh blood and fresh
serum with only one exception Onsite leishmania Ab
(Rev B) which showed low specificity. Sensitivity of all
RDTs for fresh whole blood was found 100 %. For fresh
serum, sensitivity was found 100 % of four RDTs except
signal KA 96.67 %. Specificity for fresh blood rangedfrom 58.46 % to 98.46 % and for fresh serum ranged
from 55.38 % to 98.46 %. All RDTs showed high sensitiv-
ity for stored blood except Rev A and Rev B (Table 3).
For stored blood the sensitivity was found 100 % for three
RDTs except Rev A and Rev B. Sensitivity for stored serum
was found 100 % for four RDTs except kala-azar Detect™
which showed a sensitivity of 96.77 %. Specificity for
stored blood was found 98.46 % except Onsite leishmania
Ab; Rev A and Onsite leishmania Ab; Rev B and for those
tests were invalid. All RDTs gave excellent specificity for
stored serum except Rev B. Specificity for stored serum
ranged from 100 % to 31.25 % (Table 3 and 4). The high
Cohen kappa index (k >0.97) of four RDTs substantiated
excellent agreement of test results between fresh whole
blood and serum except Onsite leishmania Rev B which
showed good agreement (k = 0.69) between fresh whole
blood and serum (Tables 5 and 6).
Table 3 Product test result (absolute number)
Product Case (30)
Fresh Stored
Blood Serum Blood Serum
Positive Negative Invalid Positive Negative Invalid Positive Negative Invalid Positive Negative Invalid
Kalazar Detect™ 30 00 00 30 00 00 30 00 00 30 00 00
Signal®KA 30 00 00 29 01 00 30 00 00 30 00 00
Crystal®KA 30 00 00 30 00 00 30 00 00 30 00 00
Onsite leishmania Ab (Rev A) 30 00 00 30 00 00 - - - 30 00 00
Onsite leishmania Ab (Rev B) 30 00 00 30 00 00 - - - 30 00 00
Product Healthy Control (35)
Fresh Stored
Blood Serum Blood Serum
Positive Negative Invalid Positive Negative Invalid Positive Negative Invalid Positive Negative Invalid
Kalazar Detect™ 00 35 00 00 35 00 00 35 00 01 34 00
Signal®KA 00 34 01 00 35 00 01 34 00 00 35 00
Crystal®KA 00 35 00 00 35 00 00 35 00 00 35 00
Onsite leishmania Ab (Rev A) 01 34 00 02 33 00 - - - 00 35 00
Onsite leishmania Ab (Rev B) 18 17 00 19 16 00 - - - 00 35 00
Product Disease Control (30)
Fresh Stored
Blood Serum Blood Serum
Positive Negative Invalid Positive Negative Invalid Positive Negative Invalid Positive Negative Invalid
Kalazar Detect™ 02 28 00 02 28 00 01 29 00 01 28 01
Signal®KA 02 28 00 02 28 00 01 25 04 01 28 01
Crystal®KA 01 29 00 01 29 00 01 29 00 01 28 01
Onsite leishmania Ab (Rev A) 02 28 00 02 28 00 - - - 03 26 01
Onsite leishmania Ab (Rev B) 09 21 00 10 20 00 - - - 16 13 01
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RDT is routinely performed on blood at primary health
centers and district hospitals in endemic areas and it has
been considered to be the first-line diagnostic tool for
diagnosis of visceral leishmaniasis. This is the first study
in Bangladesh which was conducted with a view to make
a head to head comparison of the performance of five
RDTs when performed on blood and serum. Though this
study was not designed to estimate sensitivity and specifi-
city, both rK39 and rKE16 based products except one
brand showed excellent sensitivity and specificity for both
fresh blood and serum. The sensitivity estimates are of
course somehow optimistic, as 20 of the 35 cases were
selected on the basis of an RDT according to national
guidelines. More importantly, the operational feasibility of
every RDT in primary health care was found to be up to
the mark. Furthermore, the storing conditions for every
RDT were easy to maintain in field settings except the Sig-
nal K which requires a storage temperature between 2 °C
and 8 °C. Inter-reader variability both in field setting andreference laboratory was minimal. The format (cassette or
dipstick) of an RDT is an important factor for the per-
formance of RDT, according to Rennie et al. [14]. In this
study both formats performed equally well except Rev B
and similar findings were reported by Kumar et al. [5].
In our study every valid test gave same result for blood
and serum, and our results support the findings of Kumar et
al. [5]. In a previous study disparity was found in several
cases. In that study the parasitological status of patients was
unknown and few cases gave positive result in RDT when
performed on serum but negative on blood. The authors
defined the disparity by low antibody titer in corresponding
subjects with asymptomatic self-resolving infection [3].
In this study we evaluated five brands of RDT and
found good results for fresh blood and serum except one
brand. The Onsite Rev B gave lower specificity for both
fresh and stored samples. In a previous study, the per-
formance of Rev B was found to be poor in India as well
as in Nepal [5]. In addition to Rev B, Rev A also gave invalid
result for stored blood samples. According to manufacturer’s
Table 4 Specificity of different products
Product Fresh Stored
Blood Serum Blood Serum
Specificity (Healthy Control)
Kalazar Detect™ 100 (96.34–100) 100 (96.34–100) 100 (96.34–100) 97.14 (85.03–95.02)
Signal®KA 100 (89.52–100) 100 (89.90–100) 100 (96.34–100) 100 (89.90–100)
Crystal®KA 100 (96.34–100) 100 (96.34–100) 100 (96.34–100) 100 (89.90–100)
Onsite leishmania Ab (Rev A) 97.14 (85.03–99.52) 94.29 (80.86–99.13) - 100 (89.90–100)
Onsite leishmania Ab (Rev B) 48.57 (31.39–66) 45.71 (28.84–63.45) - 20 (8.48–36.95)
Specificity (Disease Control)
Kalazar Detect™ 93.33 (77.89–98.99) 93.33 (77.89–98.99) 96.67 (82.72–99.44) 96.55 (82.17–99.42)
Signal®KA 93.33 (77.89–98.99) 93.33 (77.89–98.99) 96.15 (80.30–99.36) 96.55 (82.17–99.42)
Crystal®KA 96.67 (82.72–99.44) 96.67 (82.72–99.44) 96.67 (82.72–99.44) 96.55 (82.17–99.42)
Onsite leishmania Ab (Rev A) 93.33 (77.89–98.99) 93.33 (77.89–98.99) - 89.66 (72.62–97.69)
Onsite leishmania Ab (Rev B) 70 (50.60–85.24) 66.67 (47.19–82.69) - 44.83 (26.46–64.30)
Specificity (Healthy and Disease Controls combined)
Kalazar Detect™ 96.92 (89.30–99.54) 96.92 (89.30–99.54) 98.46 (91.69–99.74) 96.88 (89.14–99.53)
Signal®KA 96.88 (89.14–99.53) 96.92 (89.30–99.54) 98.36 (91.17–99.73) 98.44 (91.57–99.74)
Crystal®KA 98.46 (91.69–99.74) 98.46 (91.69–99.74) 98.46 (91.69–99.74) 98.44 (91.57–99.74)
Onsite leishmania Ab (Rev A) 95.38 (87.08–98.98) 93.85 (84.97–98.26) - 95.31 (86.89–98.97)
Onsite leishmania Ab (Rev B) 58.46 (45.57–70.56) 55.38 (42.53–67.73) - 31.25 (24.30–57.26)
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hemolysed blood. As blood stored without cryo-preserver
gets hemolysed at freezing temperature. We can attribute
this invalid result of Rev A and Rev B to storing procedure.
In another multicenter study, RDTs from different com-
panies were evaluated on archived serum samples from
Indian subcontinent. Considering the high sensitivity and
specificity of Crystal KA, Signal KA and Kala-azar de-
tect, present study results are congruent to the findings
of Cunningham et al. [9].
For specificity evaluation, RDT was done for endemic
healthy controls and TB patients who were considered to
be disease controls as VL shows cross-reactions with manyTable 5 Agreement between RDT result on blood versus serum
in fresh and stored samples
Blood vs Seruma Agreement index (Cohen’s kappa) with
95 % CI
Fresh Stored
Kalazar Detect™ 100 95.2 (88.39–100)
Signal®KA 97.6 (92.7–100) 100
Crystal®KA 100 100
Onsite leishmania Ab (Rev A) 97.7 (93.2–100) -
Onsite leishmania Ab (Rev B) 69 (54–84) -
aWe didn’t perform RDT on stored blood for Rev A and Rev B following
manufacturer’s instruction to avoid performing test on stored blood sample.
That is why some kappa values are missingdiseases, including trypanosomasis, malaria, tuberculosis,
leprosy and amebiasis [6]. We found very few positive cases
in the disease control group that can be attributed to po-
tential serological cross-reactivity between Leishmania and
Mycobacteria [15, 16].
Conclusion
All findings of this study infer the promising diagnostic ac-
curacy of rK39 and rKE16 based RDTs except Rev B. As all
RDTs did not perform equally on archived and fresh blood
and serum samples, so manufacturers recommendations
should be followed accordingly. In apart from several dis-
parities, the quality performance and excellent agreementTable 6 Agreement between RDT result on Fresh versus stored
in blood and serum samples
Fresh vs Stored* Agreement index (Cohen’s kappa) with
95 % CI
Blood Serum
Kalazar Detect™ 97.6 (93–100) 94.99 (88.12–100)
Signal®KA 97.6 (92.1–100) 95.2 (88.8–100)
Crystal®KA 100 100
Onsite leishmania Ab (Rev A) - 88.4 (78.5–98.3)
Onsite leishmania Ab (Rev B) - 12.7 (0–35.6)
*We didn’t perform RDT on stored blood for Rev A and Rev B following
manufacturer’s instruction to avoid performing test on stored blood sample.
That is why some kappa values are missing
Ghosh et al. Parasites & Vectors  (2015) 8:331 Page 6 of 6substantiate the routine use of fresh blood instead of serum
in dipstick test for diagnosis of visceral leishmaniasis in
hyper endemic regions of Bangladesh providing RDT
should be of good quality.
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